Skip to Main Content

Author Details

Erik Magnus Ohman
Duke University Medical Center-Duke Clinical Research Institute
1982
691
126
PMIDPaper TitleJournal TitlePublished Year
36270493External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry.Int J Cardiol2023
37587580Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions.J Am Coll Cardiol2023
37479054Morbidity and Mortality Associated With Heart Failure in Acute Coronary Syndrome: A Pooled Analysis of 4 Clinical Trials.J Card Fail2023
37879803Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention.JACC Cardiovasc Interv2023
37100486Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial.J Am Coll Cardiol2023
36640418Timing of sedation and patient-reported pain outcomes during cardiac catheterization: Results from the UNTAP-intervention study.Catheter Cardiovasc Interv2023
34569991Ambient temperature and infarct size, microvascular obstruction, left ventricular function and clinical outcomes after ST-segment elevation myocardial infarction.Coron Artery Dis2022
35680197Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors.JACC Cardiovasc Interv2022
35654162Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis.Am Heart J2022
35835600Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical Trials).Am J Cardiol2022
35657375Antithrombotic drug removal from whole blood using Haemoadsorption with a porous polymer bead sorbent.Eur Heart J Cardiovasc Pharmacother2022
35621210Cangrelor Use Patterns and Transition to Oral P2Y<sub>12</sub> Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry.J Am Heart Assoc2022
35483760Improving the National Cardiovascular Data Registry's Value to Elevate the Quality of Cardiovascular Care.J Am Coll Cardiol2022
36210212Impella Versus Intra-Aortic Balloon Pump for High-Risk PCI: A Propensity-Adjusted Large-Scale Claims Dataset Analysis.Am J Cardiol2022
36202563Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index.JACC Cardiovasc Interv2022
35979636Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study.EuroIntervention2022
35943481Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery.JAMA2022
35317615Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy.Circ Cardiovasc Interv2022
34916157Impella Mechanical Circulatory Support for Takotsubo Syndrome With Shock: A Retrospective Multicenter Analysis.Cardiovasc Revasc Med2022
34881696Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study.EuroIntervention2022
35033468Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy.JACC Cardiovasc Interv2022
35241219Underdiagnosis of Ischemic Heart Disease in New-Onset Heart Failure: A Call to Action.J Am Coll Cardiol2022
35144785Comparative Analysis of Patient Characteristics in Cardiogenic Shock Studies: Differences Between Trials and Registries.JACC Cardiovasc Interv2022
35325085Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD.Eur Heart J Cardiovasc Pharmacother2022
35140114Advances in the management of cardioembolic stroke associated with patent foramen ovale.BMJ2022
35192839Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practices.Am Heart J2022
33478649Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain?J Am Coll Cardiol2021
33848505Clinical features and outcomes in patients with cardiogenic shock complicating acute myocardial infarction: early vs recent experience with impella.Am Heart J2021
33541098Therapeutic Approaches for the No-Option Refractory Angina Patient.Circ Cardiovasc Interv2021
34662382Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.Eur Heart J2021
34423374Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.Eur Heart J2021
34450192Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registry.Int J Cardiol2021
34449186The Evolving Post-PCI Antithrombotic Therapies.N Engl J Med2021
34620413Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week.J Am Coll Cardiol2021
34224684Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.Am Heart J2021
34016409Left Ventricular Support for the Management of Cardiogenic Shock: Sooner May Be Better.JACC Cardiovasc Interv2021
33991416Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial.JAMA Cardiol2021
34238553Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI.JACC Cardiovasc Interv2021
34051033Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.Catheter Cardiovasc Interv2021
33295937Risk Stratification Science Goes to a New Level.JAMA Cardiol2021
31535314Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis.J Thromb Thrombolysis2020
32081368Meta-Analysis of Intraocular Bleeding With Dual Antiplatelet Therapy Using P2Y12 Inhibitors Prasugrel or Ticagrelor.Am J Cardiol2020
31693292Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.Catheter Cardiovasc Interv2020
31707323Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock.Am Heart J2020
33099277Towards a better standard for defining high bleeding risk patients: can we now translate this into a better practice?Eur Heart J2020
32862694Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization.Circ Cardiovasc Qual Outcomes2020
33005634Central Venous Pressure and Clinical Outcomes During Left-Sided Mechanical Support for Acute Myocardial Infarction and Cardiogenic Shock.Front Cardiovasc Med2020
32646565Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI.J Am Coll Cardiol2020
33011148Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock.Am Heart J2020
32474205Coronary revascularization and circulatory support strategies in patients with myocardial infarction, multi-vessel coronary artery disease, and cardiogenic shock: Insights from an international survey.Am Heart J2020
  • 1 - 50 of 691

Recommended Authors

Prakriti Gaba
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2014
Number of shared co-authors 8
Auras R Atreya
AIG Hospitals Institute of Cardiac Sciences and Research
Career Start Year 2011
Number of shared co-authors 0
Bryan Har
Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary
Career Start Year 2009
Number of shared co-authors 3
David Dai
Duke University Medical Center
Career Start Year 2008
Number of shared co-authors 35
Aaron Peace
Ulster University
Career Start Year 2008
Number of shared co-authors 0
Neil J Wimmer
VA Boston Healthcare System
Career Start Year 2007
Number of shared co-authors 9
Amit Kumar
Dalio Institute of Cardiovascular Imaging (S.J.A.
Career Start Year 2007
Number of shared co-authors 7
Thomas J Helton
East Tennessee State University
Career Start Year 2004
Number of shared co-authors 2
Stephen W Waldo
Department of Veterans Affairs Clinical Assessment
Career Start Year 2003
Number of shared co-authors 16
Faisal Latif
SSM Health St. Anthony Hospital, University of Oklahoma
Career Start Year 2003
Number of shared co-authors 13
Klaus Tiroch
Switzerland Witten-Herdecke University
Career Start Year 2002
Number of shared co-authors 1
Amit P Amin
Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth
Career Start Year 2000
Number of shared co-authors 25
Michelle M Graham
University of Alberta
Career Start Year 1999
Number of shared co-authors 6
Robert W Yeh
Beth Israel Deaconess Medical Center
Career Start Year 1998
Number of shared co-authors 43
Kreton Mavromatis
Atlanta VA Healthcare System
Career Start Year 1997
Number of shared co-authors 17
Robert L McNamara
Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 24
Mark R Vesely
University of Maryland Medical Center
Career Start Year 1996
Number of shared co-authors 4
Anthony A Bavry
Division of Cardiology University of Texas Southwestern Medical Center Dallas TX USA.
Career Start Year 1996
Number of shared co-authors 8
Michael C Kontos
VCU Medical Center, Virginia Commonwealth University
Career Start Year 1994
Number of shared co-authors 52
Thomas T Tsai
Institute for Health Research, Kaiser Permanente
Career Start Year 1993
Number of shared co-authors 26
Marco V Wainstein
Universidade Federal do Rio Grande do Sul
Career Start Year 1992
Number of shared co-authors 2
Robert N Piana
Vanderbilt University Medical Center
Career Start Year 1991
Number of shared co-authors 20
Yves Rosenberg
National Heart Lung and Blood Institute
Career Start Year 1991
Number of shared co-authors 37
John A McPherson
Vanderbilt University Medical Center
Career Start Year 1991
Number of shared co-authors 11
Kalon K L Ho
Beth Israel Deaconess Medical Center
Career Start Year 1990
Number of shared co-authors 28
Richard E Shaw
California Pacific Medical Center
Career Start Year 1984
Number of shared co-authors 31
Daniel M Kolansky
University of Pennsylvania Perelman School of Medicine
Career Start Year 1982
Number of shared co-authors 6
David J Maron
Stanford University School of Medicine
Career Start Year 1981
Number of shared co-authors 29
John C Messenger
University of Colorado Anschutz Medical Campus
Career Start Year 1978
Number of shared co-authors 44
David J Malenka
Dartmouth-Hitchcock Medical Center
Career Start Year 1976
Number of shared co-authors 29

Collaborators

Matthew T Roe
Duke Clinical Research Institute, Duke University
Co-authored papers 174
Eric D Peterson
University of Texas Southwestern Medical Center
Co-authored papers 122
Robert M Califf
From the National Institutes of Health
Co-authored papers 111
W Brian Gibler
University of Cincinnati College of Medicine President
Co-authored papers 111
Robert A Harrington
Co-authored papers 81
Eric J Topol
Universidade Federal de Sao Paulo
Co-authored papers 71
Deepak L Bhatt
Icahn School of Medicine at Mount Sinai Health System
Co-authored papers 70
Charles V Pollack
Thomas Jefferson University Hospital, Pennsylvania Sidney Kimmel Medical College
Co-authored papers 59
Roxana Mehran
Co-authored papers 58
Robert H Christenson
University of Maryland School of Medicine, University of Maryland
Co-authored papers 40
Keith A A Fox
Co-authored papers 40
Christopher P Cannon
Brigham and Women's Hospital
Co-authored papers 34
Ralph G Brindis
University of California san francisco
Co-authored papers 30
Frans Van de Werf
Co-authored papers 30
Kenneth W Mahaffey
Stanford University Medical School
Co-authored papers 29
Manesh R Patel
Duke Clinical Research Institute
Co-authored papers 29
Dorairaj Prabhakaran
Co-authored papers 26
David J Cohen
Clinical Trials Center, Cardiovascular Research Foundation
Co-authored papers 24
Tracy Y Wang
Duke University
Co-authored papers 23
John H Alexander
Duke University Medical Center
Co-authored papers 21
Renato D Lopes
Duke Clinical Research Institute, Duke University
Co-authored papers 20
Jyotsna Mulgund
Co-authored papers 19
Jeffrey J Popma
Harvard Medical School
Co-authored papers 18
Mark A Creager
Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth
Co-authored papers 18
William F Peacock
Baylor College of Medicine
Co-authored papers 17
Elliott M Antman
Co-authored papers 15
James W Hoekstra
Wake Forest School of Medicine
Co-authored papers 15
Usman Baber
Co-authored papers 15
David L DeMets
University of Wisconsin
Co-authored papers 14
Alan T Hirsch
School of Public Health, University of Minnesota
Co-authored papers 14
Release 1.2